Skip to main content

Advertisement

Log in

Validity of information obtained from a method for estimating cancer costs from the perspective of patients and caregivers

  • Published:
Quality of Life Research Aims and scope Submit manuscript

Abstract

Purpose

We describe a method we developed for estimating cancer costs from the perspective of patients and caregivers and evidence supporting validity of estimates obtained.

Methods

To increase validity, interview questions were anchored to treatments; costs were divided into their components; most questions focused on facts; and the research team combined responses into cost estimates. Evidence for validity comes from a prospective study of breast cancer costs using this method.

Results

Estimates obtained using interview responses were similar to those from independent sources. Women reported being reimbursed $205 on average for prosthesis (government reimbursement = $200); paying $15.48 per night at cancer lodge (average rate = $17.52); receiving government illness insurance for 14.6 weeks at 53% of usual salary (governmental program covers 15 weeks at 55%). A priori hypotheses about relations of costs with other characteristics were also confirmed. For example, patients’ weekly travel costs increased as a function of distance from the radiotherapy center, with patients living <25, 25–49 and ≥50 km away spending $54, $141 and $240, respectively (P < .0001); and the proportion of annual salary lost was 37% for self-employed workers compared to 18% for employees (P < .0001).

Conclusions

Evidence to date supports the validity of estimates obtained using this method.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Hillner, B. (1996). Economic and cost-effectiveness issues in breast cancer treatment. Seminars in Oncology, 23(1 (suppl 2)), 98–104.

    CAS  PubMed  Google Scholar 

  2. Pass, C., Lowes, B., & Davies, L. (1993). Collins dictionary of economics. London: Collins.

    Google Scholar 

  3. Collins, D. J., & Lapsey, H. M. (1991). Estimating the economic costs of drug abuse in Australia. National Campaign Against Drug Abuse Monograph Series, 15.

  4. Koopmanschap, M. A., Rutten, F. F. H., & Van der Maas, P. (1993). Indirect costs in economic studies. PharmacoEconomics, 4, 1–9.

    Article  Google Scholar 

  5. Carmines, E., & Zeller, R. (1979). Reliability and validity assessment. Newbury Park: Sage.

    Google Scholar 

  6. Aday, L. A. (1996). Designing and conducting health surveys: A comprehensive guide (2nd ed.). San Francisco: Jossey-Bass.

    Google Scholar 

  7. Agency for Healthcare Research and Quality (AHRQ). (2001). Medical Expenditure Panel Survey Medical Expenditure Panel Survey [questionnaire]. http://www.meps.ahrq.gov/whatis.htm. Accessed June 17, 2009.

  8. Birenbaum, L. K., & Clarke-Steffen, L. (1992). Terminal care costs in childhood cancer. Pediatric Nursing, 18(3), 285–288.

    CAS  PubMed  Google Scholar 

  9. Given, B. A., Given, C. W., & Stommel, M. (1994). Family and out-of-pocket costs for women with breast cancer. Cancer Practice, 2(3), 187–193.

    CAS  PubMed  Google Scholar 

  10. Houts, P. S., Harvey, H. A., Simmonds, M. A., Marshall, M., Gottleib, R., Lipton, A., et al. (1985). Characteristics of patients at risk for financial burden because of cancer and its treatment. Journal Psychosocial Oncology, 3(2), 15–22.

    Article  Google Scholar 

  11. Houts, P. S., Lipton, A., Harvey, H. A., Martin, B., Simmonds, M. A., Dixon, R. H., et al. (1984). Nonmedical costs to patients and their families associated with outpatient chemotherapy. Cancer, 53, 2388–2392.

    Article  CAS  PubMed  Google Scholar 

  12. Houts, P. S., Lipton, A., Harvey, H. A., & Martin, B. A. (1983). A method for collecting detailed data on direct and indirect medical expenses of cancer patients. Progress in Clinical and Biological Research, 120, 193–199.

    CAS  PubMed  Google Scholar 

  13. Lansky, S. B., Cairns, N. U., Clark, G. M., Lowman, J., Miller, L., & Trueworthy, R. (1979). Childhood cancer: Nonmedical costs of the illness. Cancer, 43(1), 403–408.

    Article  CAS  PubMed  Google Scholar 

  14. Moore, K. A. (1999). Breast cancer patients’ out-of-pocket expenses. Cancer Nursing, 22(5), 389–396.

    Article  CAS  PubMed  Google Scholar 

  15. Barr, R. D., Furlong, W., Horsman, J. R., Feeny, D., Torrance, G. W., & Weitzman, S. (1996). The monetary costs of childhood cancer to the families of patients. International Journal of Oncology, 8, 933–940.

    Google Scholar 

  16. Bloom, B. S., Knorr, R. S., & Evans, A. E. (1985). The epidemiology of disease expenses. The costs of caring for children with cancer. Journal of the American Medical Association, 253(16), 2393–2397.

    Article  CAS  PubMed  Google Scholar 

  17. Bodkin, C. M., Pigott, T. J., & Mann, J. R. (1982). Financial burden of childhood cancer. British Medical Journal, 284(6328), 1542–1544.

    Article  CAS  PubMed  Google Scholar 

  18. Monaco, G. P. (1983). Economics as a significant contributor to family stress in childhood cancer. Progress in Clinical and Biological Research, 132E, 387–394.

    CAS  PubMed  Google Scholar 

  19. Stommel, M., Given, C. W., & Given, B. A. (1993). The cost of cancer home care to families. Cancer, 71(5), 1867–1874.

    Article  CAS  PubMed  Google Scholar 

  20. Willis, G. B. (1999). Cognitive Interviewing. A “How to” Guide. Meeting of the American Statistical Association.

  21. Lauzier, S., Maunsell, E., De Koninck, M., Drolet, M., Hebert-Croteau, N., & Robert, J. (2005). Conceptualization and sources of costs from breast cancer: Findings from patient and caregiver focus groups. Psycho-Oncology, 14(5), 351–360.

    Article  PubMed  Google Scholar 

  22. Frey, J., & Fontana, A. (1993). The group interview in social research. In D. Morgan (Ed.), Successful focus groups: Advancing the state of the art (pp. 20–34). Newbury Park: Sage.

    Google Scholar 

  23. Kitzinger, J. (1995). Introducing focus groups. British Medical Journal, 311, 299–302.

    CAS  PubMed  Google Scholar 

  24. Morgan, D. L. (1998). Focus group as qualitative research. Newbury Park: Sage.

    Google Scholar 

  25. Wolff, B., Knodel, J., & Sittitrai, W. (1993). Focus groups and surveys as complementary research methods: A case example. In D. Morgan (Ed.), Successful focus groups advancing the state of the art (pp. 118–136). Newbury Park: Sage.

    Google Scholar 

  26. Drolet, M., Maunsell, E., & Lauzier, S. (2001). Family costs of breast cancer: Extent, determinants and relation with quality of life. Progress report to the Canadian Breast Cancer Research Alliance (CBCRA). September 1999–August 2001.

  27. Cancer Care Inc. (1973). The impact, costs, and consequences of catastrophic illness on patients and families. A report of a social research study of selected families stricken by advanced cancer. New York: Cancer Care, Inc. and The National Cancer Foundation, Inc.

  28. Maguire, P., Pentol, A., Allen, D., Tait, A., Brooke, M., & Sellwood, R. (1982). Cost of counselling women who undergo mastectomy. British Medical Journal, 284, 1933–1935.

    Article  CAS  PubMed  Google Scholar 

  29. Drolet, M., Maunsell, E., Mondor, M., Brisson, J., Brisson, C., Mâsse, B., et al. (2005). Work absence after breast cancer diagnosis: A population-based study. Canadian Medical Association Journal, 173(7), 765–769.

    Article  PubMed  Google Scholar 

  30. Maunsell, E., Drolet, M., Ouhoummane, N., & Robert, J. (2005). Breast cancer survivors accurately reported key treatment and prognostic characteristics. Journal of Clinical Epidemiology, 58(4), 364–369.

    Article  PubMed  Google Scholar 

  31. Drummond, M., Sculpher, M., Torrance, G., O’Brien, B., & Stoddart, G. (2005). Economic evaluation using patient-level data. In M. Drummond, M. Sculpher, G. Torrance, B. O’Brien, & G. Stoddart (Eds.), Methods for the economic evaluation of health care programmes (3rd ed., pp. 247–275). Oxford: Oxford University Press.

    Google Scholar 

  32. Microsoft. (2001). Streets and Trips software.

  33. Lauzier, S., Maunsell, E., Drolet, M., Coyle, D., Hébert-Croteau, N., Brisson, J., et al. (2008). Wage losses in the year after breast cancer: Extent and determinants among Canadian women. Journal of the National Cancer Institute, 100(5), 321–332.

    Article  PubMed  Google Scholar 

  34. Canadian Government. (2009). Employment Insurance (EI) and maternity, parental and sickness benefits [website]. http://www.servicecanada.gc.ca/eng/ei/types/special.shtml. Accessed June 17, 2009.

  35. Ministère du Travail du Québec. (2004). Portrait statistique des conventions collectives analysées en 2003 au Québec. Québec: Direction des données sur le travail, Ministère du Travail du Québec.

  36. Calhoun, E. A., Chang, C. H., Welshman, E. E., Fishman, D. A., Lurain, J. R., & Bennett, C. L. (2001). Evaluating the total costs of chemotherapy-induced toxicity: Results from a pilot study with ovarian cancer patients. Oncologist, 6(5), 441–445.

    Article  CAS  PubMed  Google Scholar 

  37. Ihbe-Heffinger, A., Ehlken, B., Bernard, R., Berger, K., Peschel, C., Eichler, H. G., et al. (2004). The impact of delayed chemotherapy-induced nausea and vomiting on patients, health resource utilization and costs in German cancer centers. Annals of Oncology, 15(3), 526–536.

    Article  CAS  PubMed  Google Scholar 

  38. Moore, K. (1998). Out-of-pocket expenditures of outpatients receiving chemotherapy. Oncology Nursing Forum, 25(9), 1615–1622.

    CAS  PubMed  Google Scholar 

  39. O’Brien, B. J., Rusthoven, J., Rocchi, A., Latreille, J., Fine, S., Vandenberg, T., et al. (1993). Impact of chemotherapy-associated nausea and vomiting on patients’ functional status and on costs: Survey of five Canadian centres. Canadian Medical Association Journal, 149(3), 296–302.

    PubMed  Google Scholar 

  40. Sculpher, M., Palmer, M. K., & Heyes, A. (2000). Costs incurred by patients undergoing advanced colorectal cancer therapy. A comparison of raltitrexed and fluorouracil plus folinic acid. PharmacoEconomics, 17(4), 361–370.

    Article  CAS  PubMed  Google Scholar 

  41. Arozullah, A. M., Calhoun, E. A., Wolf, M., Finley, D. K., Fitzner, K. A., Heckinger, E. A., et al. (2004). The financial burden of cancer: Estimates from a study of insured women with breast cancer. Journal of Supportive Oncology, 2(3), 271–278.

    PubMed  Google Scholar 

  42. Chan, A., Jacobs, P., Yeo, W., Lai, M., Hazlett, C., Mok, T., et al. (2001). The cost of palliative care for hepatocellular carcinoma in Hong Kong. PharmacoEconomics, 19(9), 947–953.

    Article  CAS  PubMed  Google Scholar 

  43. Longo, C. J., Fitch, M., Deber, R. B., & Williams, A. P. (2006). Financial and family burden associated with cancer treatment in Ontario, Canada. Supportive Care in Cancer, 14(11), 1077–1085.

    Article  PubMed  Google Scholar 

  44. Schulz, R., Williamson, G. M., Knapp, J. E., Bookwala, J., Lave, J., & Fello, M. (1995). The psychological, social, and economic impact of illness among patients with recurrent cancer. Journal of Psychosocial Oncology, 13(3), 21–45.

    Article  Google Scholar 

  45. Sherman, E. J., Pfister, D. G., Ruchlin, H. S., Rubin, D. M., Radzyner, M. H., Kelleher, G. H., et al. (2001). The collection of indirect and nonmedical direct costs (COIN) form: A new tool for collecting the invisible costs of androgen independent prostate carcinoma. Cancer, 91(4), 841–853.

    Article  CAS  PubMed  Google Scholar 

  46. Butler, L., Downe-Wamboldt, B., Melanson, P., Coulter, L., Keefe, J., Singleton, J., et al. (2006). Prevalence, correlates, and costs of patients with poor adjustment to mixed cancers. Cancer Nursing, 29(1), 9–16.

    Article  PubMed  Google Scholar 

  47. Gordon, L., Scuffham, P., Hayes, S., & Newman, B. (2007). Exploring the economic impact of breast cancers during the 18 months following diagnosis. PsychoOncology, 16(12), 1130–1139.

    Article  PubMed  Google Scholar 

  48. Grunfeld, E., Coyle, D., Whelan, T., Clinch, J., Reyno, L., Earle, C. C., et al. (2004). Family caregiver burden: Results of a longitudinal study of breast cancer patients and their principal caregivers. Canadian Medical Association Journal, 170(12), 1795–1801.

    Article  PubMed  Google Scholar 

  49. Thorpe, K. E., & Howard, D. (2003). Health insurance and spending among cancer patients. Health Affairs (Suppl Web Exclusives), W3, 189–198.

    Google Scholar 

  50. Langa, K. M., Fendrick, A. M., Chernew, M. E., Kabeto, M. U., Paisley, K. L., & Hayman, J. A. (2004). Out-of-pocket health-care expenditures among older Americans with cancer. Value in Health, 7(2), 186–194.

    Article  PubMed  Google Scholar 

  51. Muller-Nordhorn, J., Bruggenjurgen, B., Bohmig, M., Selim, D., Reich, A., Noesselt, L., et al. (2005). Direct and indirect costs in a prospective cohort of patients with pancreatic cancer. Alimentary Pharmacology & Therapeutics, 22(5), 405–415.

    Article  CAS  Google Scholar 

  52. Lidgren, M., Wilking, N., Jonsson, B., & Rehnberg, C. (2007). Resource use and costs associated with different states of breast cancer. International Journal of Technology Assessment in Health Care, 23(2), 223–231.

    Article  PubMed  Google Scholar 

  53. Foddy, W. (1993). Constructing questions for interviews and questionnaires. Cambridge: Cambridge University Press.

    Book  Google Scholar 

Download references

Acknowledgments

We thank the women and caregivers who participated in the different phases of the Family Costs of Breast Cancer Study, and the study coordinator, interviewers, data manager, statisticians and the members of the Family Costs of Breast Cancer Clinician Collaborators Group (Michèle Brie (Centre hospitalier régional de Baie-Comeau, Baie-Comeau), Judith Gaudreault (Centre hospitalier régional du Grand-Portage, Rivière-du-Loup), Marie-Hélène Girouard (Centre hospitalier régional de Trois-Rivières, Trois-Rivières), Jean Robert (Hôpital du Saint-Sacrement, Québec), André Robidoux (Centre hospitalier de l’Université de Montréal, Montréal), Mathieu Roy (Centre hospitalier Pierre-Boucher, Longueuil), Renée Simon (Hôpital Charles-Lemoyne, Greenfield Park), and Éric Imbeau (Hôtel-Dieu de Lévis, Lévis)). Funding: This work was supported by competitive funding from the Canadian Breast Cancer Research Alliance (grants #010318, #013324, #017317); the Ministère de la Santé et des Services Sociaux du Québec, the Canadian Institutes of Health Research (Investigator award for E. M., Ph.D. Fellowship Award for S. L.); the Fondation de l’Université Laval (Ph.D. Fellowship Award for S. L.) and the Psychosocial Oncology Research Training (PORT) program of the Canadian Institutes of Health Research—funded Strategic Training Initiative in Health Research (STIHR) (Post-doctoral Fellowship Award for S. L.).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Elizabeth Maunsell.

Appendix

Appendix

See Table 3.

Table 3 Information collected during 1-month, 6-month and 12-month interviews to estimate direct and indirect costs

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lauzier, S., Maunsell, E., Drolet, M. et al. Validity of information obtained from a method for estimating cancer costs from the perspective of patients and caregivers. Qual Life Res 19, 177–189 (2010). https://doi.org/10.1007/s11136-009-9575-y

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11136-009-9575-y

Keywords

Navigation